Stand Up To Cancer’s mission is to raise awareness and fund research to detect and treat cancers with the aspiration to cure all patients.
Stand Up to Cancer’s recent grantmaking is defined by two large general-program awards to the Entertainment Industry Foundation, one in 2024 for $38,933,153 and another in 2025 for $34,661,350. Those grants sit within a mission centered on raising awareness and funding research to detect and treat cancers, with the stated aspiration to cure all patients. The foundation’s focus areas point to a broad research agenda that includes early detection, cancer interception, immunotherapy and cancer vaccines, and clinical trials, alongside disease-specific work in pancreatic, breast, lung, pediatric, colon and rectal, prostate, leukemia, melanoma, ovarian, myeloma, brain tumors, and endometrial cancer. The pattern suggests a research funder oriented toward accelerating clinical progress rather than making many small awards. Its beneficiary list includes people living with cancer, underserved and minority communities affected by cancer, and clinical researchers and trial investigators. The support also aligns with a collaborative, consortium-driven approach and with funding that aims to speed therapy development and deployment. In the recent grants on file, the foundation’s giving is tightly concentrated and channels major resources through a repeated partner in Los Angeles.
In early detection and cancer interception, Stand Up to Cancer names both areas as core parts of its funding agenda, linking them to its mission to detect and treat cancers. Its program areas also include immunotherapy and cancer vaccines, showing support for treatment development as well as prevention-oriented research. Disease-specific funding covers several cancer types. The foundation lists pancreatic cancer, breast cancer, lung cancer, pediatric cancer, colon and rectal cancer, prostate cancer, leukemia, melanoma, ovarian cancer, myeloma, brain tumors, and endometrial cancer among its focus areas. That breadth suggests a portfolio built around multiple tumor types rather than a single disease. The taxonomy also includes AI and computational approaches, clinical trials support, and therapy development/rapid deployment, which points to research translation as a central theme.
The only grant-size figures on file are $38,933,153 and $34,661,350, which place the typical grant size at $38,933,153 across the observed record. The recent grants list shows repeated support to the same recipient in consecutive years, indicating an ongoing relationship rather than a one-off award pattern. Stand Up to Cancer is classified as a regular funder, does not fund individuals, and is not a program-related-investment maker. No application process is provided in the available data.
$34.7M
$0
$34.7M
$34.7M
Most grants fall between $38.9M and $38.9M, with a median of $38.9M.
25th Percentile
$38.9M
Median
$38.9M
75th Percentile
$38.9M
NICOLE SEXTON
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Stand Up to Cancer’s grantmaking is local and entirely concentrated in California, which accounts for 100% of grants in the dataset. The recent awards both went to Los Angeles, CA. At the country level, all recorded grants stayed in the United States. The location pattern is narrow rather than dispersed, with giving landing in the foundation’s own state and city through its main recipient.
Its stated focus areas include early detection, cancer interception, immunotherapy and cancer vaccines, clinical trials, AI and computational approaches, and multiple disease areas such as pancreatic, breast, lung, pediatric, colon and rectal, prostate, leukemia, melanoma, ovarian, myeloma, brain tumors, and endometrial cancer.
The beneficiary types listed are people living with cancer, underserved and minority communities affected by cancer, and clinical researchers and trial investigators. The recent grants on file also show support going to a Los Angeles-based recipient in the general-program category.
No. The foundation is marked as funds individuals: false, so its giving is directed to organizations rather than individuals.
The typical grant size is $38,933,153, with p25, median, and p75 all at the same figure. The recent grants list shows one award at that amount in 2024 and another at $34,661,350 in 2025.
Its geographic scope is local, and 100% of grants in the dataset went to recipients in California. The recorded recipients were in Los Angeles, CA, and all grants were in the United States.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| ENTERTAINMENT INDUSTRY FOUNDATION | LOS ANGELES, CA | $34,661,350 | 2025 | GENERAL PROGRAM |
| ENTERTAINMENT INDUSTRY FOUNDATION | LOS ANGELES, CA | $38,933,153 | 2024 | GENERAL PROGRAM |
Current and upcoming funding from Stand Up to Cancer that your nonprofit may be able to apply for.
Who can apply: The opportunity is for researchers proposing alternative platforms for early detection of lung cancer prior to treatment. Detailed eligibility criteria were not provided in the scraped content.
Deadline: No deadline stated in the provided content.
Who can apply: Highly innovative translational research proposals addressing diffuse midline glioma, including DIPG. Specific eligibility requirements are provided through ProposalCentral.
Deadline: Not stated in the provided content.
Who can apply: Applicants must submit novel, collaborative, high-impact cancer research proposals responding to a published SU2C Request for Applications. SU2C emphasizes defined milestones and deliverables, collaboration, team science, health-equity goals, and inclusion of historically underrepresented racial, ethnic, sovereign-nation, and underserved populations where relevant. Specific eligibility varies by RFA.
Deadline: No traditional grant cycle; RFAs open when funds are available. New opportunities are posted on the SU2C Grant Opportunities page.
Who can apply: Applicants must submit novel, collaborative, high-impact cancer research proposals responsive to an announced Stand Up To Cancer Request for Applications. Proposals should address critical patient-care problems, have defined milestones and deliverables, and incorporate health-equity considerations where relevant. Specific eligibility varies by RFA.
Deadline: No traditional grant cycle; RFAs are opened as funds become available. Current open applications are posted on the Grant Opportunities page.
Who can apply: Open to members of the Stand Up To Cancer scientific community. Applicants should propose synergistic and innovative collaborations related to pancreatic cancer treatment development.
Deadline: No deadline stated in the provided content.
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.
